| Sitagliptin, Metformin |
EU/1/08/455/009 |
JANUMET, Film coated tablet, 50 mg/1000 mg, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
FROSST IBERICA, S.A.,Spain |
31.72 |
6.34 |
38.06 |
4% |
1.27 |
32.99 |
6.6 |
39.59 |
16% |
5.08 |
38.07 |
7.61 |
45.68 |
Оставя без уважение жалбата Комисия по прозрачност КП-38/05.03.2015 ; корекционно решение НСР-7537/19.11.2015 |
НСР-3058/21.03.2014 |
02.04.2015 |
02.04.2015 |
Неактивен |
3653 |
| Sitagliptin, Metformin |
EU/1/08/455/002 |
JANUMET, Film coated tablet, 50 mg/1000 mg, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
FROSST IBERICA, S.A.,Spain |
36.05 |
7.21 |
43.26 |
4% |
1.44 |
37.49 |
7.5 |
44.99 |
16% |
5.77 |
43.26 |
8.65 |
51.91 |
|
КЦРР-1937/17.12.2012 г |
22.01.2013 |
22.01.2013 |
Неактивен |
3653 |
| Sitagliptin, Metformin |
EU/1/08/455/002 |
JANUMET, Film coated tablet, 50 mg/ 850 mg, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
FROSST IBERICA, S.A.,Spain |
39.16 |
7.83 |
46.99 |
4% |
1.57 |
40.73 |
8.15 |
48.88 |
16% |
6.27 |
47 |
9.4 |
56.4 |
|
КЦРР-1937/17.12.2012 г |
22.01.2013 |
22.01.2013 |
Неактивен |
1549 |
| Sitagliptin, Metformin |
EU/1/08/455/009 |
JANUMET, Film coated tablet, 50 mg/1000 mg, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
FROSST IBERICA, S.A.,Spain |
41.07 |
8.21 |
49.28 |
4% |
1.64 |
42.71 |
8.54 |
51.25 |
16% |
6.57 |
49.28 |
9.86 |
59.14 |
|
КЦ-1170/07.10.2009 |
29.10.2009 |
29.10.2009 |
Неактивен |
3653 |
| Sitagliptin, Metformin |
EU/1/08/455/002 |
JANUMET, Film coated tablet, 50 mg/ 850 mg, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
FROSST IBERICA, S.A.,Spain |
41.07 |
8.21 |
49.28 |
4% |
1.64 |
42.71 |
8.54 |
51.25 |
16% |
6.57 |
49.28 |
9.86 |
59.14 |
|
КЦ-1170/07.10.2009 |
29.10.2009 |
29.10.2009 |
Неактивен |
1549 |
| Sitagliptin |
EU/1/07/383/014 |
Januvia, Tablet, 100, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
Merck Sharp & Dohme (Italia) S.p.A., Via Emilia 21, 27100 - Pavia, Италия; Merck Sharp & Dohme Ltd. Shotton Lane, Cramlington Northumberland NE23 3JU Обединено кралство; / Merck Sharp & Dohme BV Waarderweg 39 2031 BN Haarlem Нидерландия |
54.76 |
10.95 |
65.71 |
4% |
2.19 |
56.95 |
11.39 |
68.34 |
16% |
8.76 |
65.71 |
13.14 |
78.85 |
промяна на обстоятелства НСР-8307/26.02.2016 |
НСР-7468/12.11.2015; НСР-9938/29.07.2016 |
02.09.2016 |
02.09.2016 |
Активен |
3094 |
| Sitagliptin |
EU/1/07/383/014 |
Januvia, Tablet, 100, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
Merck Sharp & Dohme (Italia) S.p.A., Via Emilia 21, 27100 - Pavia, Италия; Merck Sharp & Dohme Ltd. Shotton Lane, Cramlington Northumberland NE23 3JU Обединено кралство; / Merck Sharp & Dohme BV Waarderweg 39 2031 BN Haarlem Нидерландия |
57.05 |
11.41 |
68.46 |
4% |
2.28 |
59.33 |
11.87 |
71.2 |
16% |
9.13 |
68.46 |
13.69 |
82.15 |
промяна на обстоятелства НСР-8307/26.02.2016 |
НСР-7468/12.11.2015 |
27.11.2015 |
27.11.2015 |
Неактивен |
3094 |
| Sitagliptin |
EU/1/07/383/014 |
Januvia, Tablet, 100, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
Merck Sharp & Dohme (Italia) S.p.A., Via Emilia 21, 27100 - Pavia, Италия |
59.44 |
11.89 |
71.33 |
4% |
2.38 |
61.82 |
12.36 |
74.18 |
16% |
9.51 |
71.33 |
14.27 |
85.6 |
|
НСР-4329/05.08.2014 |
20.08.2014 |
20.08.2014 |
Неактивен |
3094 |
| Sitagliptin |
EU/1/07/383/014 |
Januvia, Tablet, 100, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
Merck Sharp & Dohme (Italia) S.p.A., Via Emilia 21, 27100 - Pavia, Италия |
59.93 |
11.99 |
71.92 |
4% |
2.4 |
62.33 |
12.47 |
74.8 |
16% |
9.59 |
71.92 |
14.38 |
86.3 |
|
НСР-1960/06.12.2013 |
24.12.2013 |
24.12.2013 |
Неактивен |
3094 |
| Sitagliptin |
EU/1/07/383/014 |
Januvia, Tablet, 100, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
Merck Sharp & Dohme (Italia) S.p.A., Via Emilia 21, 27100 - Pavia, Италия |
64.87 |
12.97 |
77.84 |
4% |
2.59 |
67.46 |
13.49 |
80.95 |
16% |
10.38 |
77.84 |
15.57 |
93.41 |
|
КЦРР-1201/13.08.2012 |
12.09.2012 |
12.09.2012 |
Неактивен |
3094 |
| Sitagliptin |
EU/1/07/383/014 |
Januvia, Tablet, 100, mg, Pack: 28 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
Merck Sharp & Dohme (Italia) S.p.A., Via Emilia 21, 27100 - Pavia, Италия |
70.1 |
14.02 |
84.12 |
4% |
2.8 |
72.9 |
14.58 |
87.48 |
16% |
11.22 |
84.12 |
16.82 |
100.94 |
|
КЦ-724/16.03.2009 |
03.04.2009 |
03.04.2009 |
Неактивен |
3094 |
| Sitagliptin |
EU/1/07/383/013 |
Januvia, Tablet, 100, mg, Pack: 14 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
Merck Sharp & Dohme (Italia) S.p.A., Via Emilia 21, 27100 - Pavia, Италия |
35.05 |
7.01 |
42.06 |
4% |
1.4 |
36.45 |
7.29 |
43.74 |
16% |
5.61 |
42.06 |
8.41 |
50.47 |
Цената се заличава с решение НСР-2576/24.01.2014 |
КЦ-724/16.03.2009 |
03.04.2009 |
03.04.2009 |
Заличен |
671 |
| Empagliflozin |
EU/1/14/930/014 |
Jardiance, Film coated tablet, 10, mg, Pack: 30 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Strasse 173 D-55216 Ingelheim am Rhein, Германия |
67.14 |
13.43 |
80.57 |
4% |
2.69 |
69.83 |
13.97 |
83.8 |
16% |
10.74 |
80.57 |
16.11 |
96.68 |
|
HCР-8625/31.03.2016. |
15.04.2016 |
15.04.2016 |
Активен |
4043 |
| Empagliflozin |
EU/1/14/930/014 |
Jardiance, Film coated tablet, 10, mg, Pack: 30 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Strasse 173 D-55216 Ingelheim am Rhein, Германия |
69.24 |
13.85 |
83.09 |
4% |
2.77 |
72.01 |
14.4 |
86.41 |
16% |
11.08 |
83.09 |
16.62 |
99.71 |
|
HCР-6705/16.07.2015. |
01.08.2015 |
01.08.2015 |
Неактивен |
4043 |
| Paracetamol |
№ II - 13774/ 21.06.2011 |
Jectamol, Solution for infusion, 1000 mg/ 6.7 ml, mg, Pack: 3 |
Phos Pharma Ltd, Кипър |
Uni Pharma Kleon Tsetis pharmaceutical laboratories S.A., Greece |
7.63 |
1.53 |
9.16 |
7% |
0.53 |
8.16 |
1.63 |
9.79 |
20% |
1.53 |
9.69 |
1.94 |
11.63 |
|
НСР-2378/21.01.2014 |
24.03.2014 |
24.03.2014 |
Активен |
2590 |
| Paracetamol |
№ II - 13774/ 21.06.2011 |
Jectamol, Solution for infusion, 1000 mg/ 6.7 ml, mg, Pack: 3 |
Phos Pharma Ltd, Кипър |
Uni Pharma Kleon Tsetis pharmaceutical laboratories S.A., Greece |
8.63 |
1.73 |
10.36 |
7% |
0.6 |
9.23 |
1.85 |
11.08 |
20% |
1.73 |
10.96 |
2.19 |
13.15 |
|
КЦ-2838/05.10.2011 |
20.10.2011 |
20.10.2011 |
Неактивен |
2590 |
| Metformin and linagliptin |
EU/1/12/780/020 |
Jentadueto 2,5 mg/1000 mg, Film coated tablet, 2,5 mg/1000 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.54 |
13.11 |
78.65 |
4% |
2.62 |
68.16 |
13.63 |
81.79 |
16% |
10.49 |
78.65 |
15.73 |
94.38 |
|
НСР-2887/05.03.2014; НСР-9112/27.04.2016 |
02.06.2016 |
02.06.2016 |
Активен |
2596 |
| Metformin and linagliptin |
EU/1/12/780/020 |
Jentadueto 2,5 mg/1000 mg, Film coated tablet, 2,5 mg/1000 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.62 |
13.12 |
78.74 |
4% |
2.62 |
68.24 |
13.65 |
81.89 |
16% |
10.5 |
78.74 |
15.75 |
94.49 |
|
НСР-2887/05.03.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
2596 |
| Metformin and linagliptin |
EU/1/12/780/020 |
Jentadueto 2,5 mg/1000 mg, Film coated tablet, 2,5 mg/1000 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
69.82 |
13.96 |
83.78 |
4% |
2.79 |
72.61 |
14.52 |
87.13 |
16% |
11.17 |
83.78 |
16.76 |
100.54 |
|
HCР-150/13.06.2013 |
16.06.2013 |
16.06.2013 |
Неактивен |
2596 |
| Metformin and linagliptin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.54 |
13.11 |
78.65 |
4% |
2.62 |
68.16 |
13.63 |
81.79 |
16% |
10.49 |
78.65 |
15.73 |
94.38 |
|
НСР-2887/05.03.2014; НСР-9113/27.04.2016 |
02.06.2016 |
02.06.2016 |
Активен |
2595 |
| Metformin and linagliptin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
65.62 |
13.12 |
78.74 |
4% |
2.62 |
68.24 |
13.65 |
81.89 |
16% |
10.5 |
78.74 |
15.75 |
94.49 |
|
НСР-2887/05.03.2014 |
20.03.2014 |
20.03.2014 |
Неактивен |
2595 |
| Metformin and linagliptin |
EU/1/12/780/006 |
Jentadueto 2,5 mg/850 mg, Film coated tablet, 2,5 mg/850 mg, mg, Pack: 60 |
Boehringer Ingelheim International GmbH, Германия |
Boehringer Ingelheim International GmbH&Co. KG, Binger Strasse 173, D-55216 Ingelheim am Rhein, Германия |
71.58 |
14.32 |
85.9 |
4% |
2.86 |
74.44 |
14.89 |
89.33 |
16% |
11.45 |
85.89 |
17.18 |
103.07 |
|
HCР-150/13.06.2013 |
16.06.2013 |
16.06.2013 |
Неактивен |
2595 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7227.2 |
1445.44 |
8672.64 |
4% |
10 |
7237.2 |
1447.44 |
8684.64 |
16% |
25 |
7262.2 |
1452.44 |
8714.64 |
|
НСР-7772/28.12.2015 |
13.01.2016 |
13.01.2016 |
Активен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7275.04 |
1455.01 |
8730.05 |
4% |
10 |
7285.04 |
1457.01 |
8742.05 |
16% |
25 |
7310.04 |
1462.01 |
8772.05 |
корекционно решение НСР-7663/01.12.2015 |
НСР-5979/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3727 |
| Cabazitaxel |
EU/1/11/676/001 |
Jevtana, Concentrate and solvent for solution for infusion, 60, mg, Pack: 1 |
Sanofi-Aventis Groupe, Франция |
Aventis Pharma, Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH, Германия |
7498.65 |
1499.73 |
8998.38 |
4% |
10 |
7508.65 |
1501.73 |
9010.38 |
16% |
25 |
7533.65 |
1506.73 |
9040.38 |
|
НСР-2530/24.01.2014 |
19.02.2014 |
19.02.2014 |
Неактивен |
3727 |